Table 2.
Type of Cancer | ITGA2 status/role |
---|---|
Breast Cancer | ITGA2 1648G > A (95% of the breast cancer patients expressed the 1648AA genotype).9 |
Colorectal cancer | ITGA2 807C > T polymorphism was associated with reduced colorectal cancer risk but no effects on overall survival or relapse-free survival.10, 11 |
Gastric Cancer | ITGA2 807C > T polymorphism may be associated with an increased risk of gastric cancer, differentiation and invasion of gastric cancer.12 |
Lymph node positive breast cancer | No correlation of polymorphism with disease-free survival or relapse-free survival.13 |
Melanoma | Very conserved polymorphisms have small effects in melanoma.84 |
Colon cancer | Up-regulated.85 |